Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-25 Remeditex Ventures LLC 10% owner Purchase +100,000 $17.00 $1.7M 1,582,854
2018-01-25 Vivo Capital VIII, LLC 10% owner Purchase +258,432 $17.00 $4.4M 258,432
2018-01-25 Vivo Capital VIII, LLC 10% owner Purchase +35,686 $17.00 $607K 35,686
2018-01-25 Cha Albert Director Purchase +258,432 $17.00 $4.4M 258,432
2018-01-25 Cha Albert Director Purchase +35,686 $17.00 $607K 35,686

Page 22 of 22 · 425 trades